Efficacy and safety of levoamlodipine besylate for essential hypertension: A systematic review

Chinese Journal of Evidence-Based Medicine

Volumn 8, Issue 7, 2008, Pages 543-550

  Yi, Hong Gang ^a   Huang, Gao Zhong ^b   Liu, Guan Jian ^c  

^a NANJING MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c SICHUAN UNIVERSITY   (China)

Author keywords

Efficacy; Essential hypertension; Levoamlodipine besylate; Meta analysis; Safety; Systematic review

Indexed keywords

AMLODIPINE; AMLODIPINE BESYLATE; INDAPAMIDE; NITRENDIPINE;

CLINICAL TRIAL; DRUG EFFICACY; DRUG RESEARCH; DRUG SAFETY; ESSENTIAL HYPERTENSION; HUMAN; META ANALYSIS; REVIEW; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT;

EID: 51349124873     PISSN: 16722531     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Chinese source
2. WHO-ISH Hypertension Guidel ines Committee. 1999 World Health Organization - International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens, 1999, 17: 151-183.
3. Chinese source
4. Sackett DL, Clarke M, Oxman AD, et al. Cochrane Reviewers, Handbook 4.2, In Review Manager. Versions 4.2 .Oxford, England: The cochrane collaboration, 2002. 13-36.
5. Chinese source
6. Chinese source
7. Chinese source
8. Chinese source
9. Chinese source
10. Chinese source
11. Chinese source
12. Chinese source
13. Chinese source
14. Chinese source
15. Chinese source
16. Chinese source
17. Chinese source
18. Chinese source
19. Chinese source
20. Chinese source
21. Chinese source
22. Vickers A, Goyal N, Harland R, et al. Do certain countries produce only positive results? A systematic review of controlled trials. Control Clin Trials, 1998, 19(2): 159-166.